Listen on the go
CORRECT!
Next question
touchRESPIRATORY touchRESPIRATORY
    • FILTER YOUR SEARCH
    Content Type:
    Speciality:
    More Specialities
    Conference:
    More Conferences

    • Pulmonary Embolism

    US PULMONARY EMBOLISM PARTNER

    An Introduction to Pulmonary Embolism

    Beyond anticoagulation, interest has grown in therapeutic escalation through systemic thrombolysis, catheter-directed therapies or surgical embolectomy in patients with high- and intermediate risk pulmonary embolism (PE). An ultrasound-assisted thrombolysis system, as well as catheter-based embolectomy and bioconvertible inferior vena cava filter interventional devices have been approved for use in recent years. It is hoped that more information will emerge to support selection of interventions for medium- and high-risk PE patients.

    Browse our selection of video highlights and short articles from the conference hub, providing insights into the latest updates from major conferences and a selection of peer-reviewed articles from the journal portfolio.

    Our supporting partners do not constitute an endorsement of the content on this page.

    Pulmonary Embolism Content

    Pulmonary Embolism, Pulmonary Hypertension, Sleep Related Breathing Disorders
    Foreword touchREVIEWS in Respiratory & Pulmonary Diseases Volume 7, Issue 2, 2022

    touchREVIEWS in Respiratory & Pulmonary Diseases. 2022;7(2):31

    Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases, which covers several hot topics in respiratory medicine, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, bronchiectasis and the ever-present subject of Coronavirus Disease 2019 (COVID-19). The articles and expert opinions in this journal reflect the progress and challenges in this active […]

    Pulmonary Embolism
    Developed by Touch
    Advait Vasavada, CHEST 2022: In-hospital mortality of pulmonary embolism in young adults with cannabis use disorder
    Watch Time: 5 mins

    Cannabis use disorder is described as the inability to stop using marijuana, despite a negative impact on health. It was a pleasure to talk with Dr. Advait Vasavada (M. P. Shah Medical College, Jamnagar, India) around the aims, design, eligibility criteria and findings from his study investigating in-hospital mortality of pulmonary embolism in young adults […]

    Pulmonary Embolism
    Developed by Touch
    Advait Vasavada, CHEST 2022: Cannabis use disorder and thromboembolic events
    Watch Time: 3 mins

    Cannabis use disorder is described as the inability to stop using marijuana, despite a negative impact on health. We caught up with Dr. Advait Vasavada (M. P. Shah Medical College, Jamnagar, India) around the definition of cannabis use disorder and what we currently know about the impact of this disorder on thromboembolic events. The abstract […]

    Pulmonary Embolism, Pulmonary Hypertension, Sleep Related Breathing Disorders
    Foreword touchREVIEWS in Respiratory & Pulmonary Diseases Volume 7, Issue 1, 2022

    Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases, which aims to provide insightful and topical articles relevant to the everyday practice of busy physicians. Our popular expert interviews provide a snapshot of hot topics in medicine. In the first of our interviews, Andrew Menzies-Gow discusses the clinical data leading to the US […]

    Pulmonary Embolism, Pulmonary Hypertension
    Luis Jara Palomares, ERS 2019 – Environmental Factors in Pulmonary Embolism and PAH

    Luis Jara-Palomares, from Seville, Spain, joins us at ERS 2019 in Madrid, to discuss the main findings from his study into the significance of environmental factors in pulmonary embolism and pulmonary arterial hypertension. Questions 1. What are the major causes of pulmonary embolism and pulmonary arterial hypertension? (0:06) 2. What is known about the impact […]

    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72